Clinically applicable CD34(+)-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

Allogeneic stem cell transplantation (alloSCT), following induction chemotherapy, can be curative for hemato-oncology patients due to powerful graft-versus-tumor immunity. However, disease recurrence remains the major cause of treatment failure, emphasizing the need for potent adjuvant immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eck van der Sluijs, Jesper, van Ens, Diede, Thordardottir, Soley, Vodegel, Denise, Hermens, Inge, van der Waart, Anniek B., Falkenburg, J. H. Frederik, Kester, Michel G. D., de Rink, Iris, Heemskerk, Mirjam H. M., Borst, Jannie, Schaap, Nicolaas P. M., Jansen, Joop H., Xiao, Yanling, Dolstra, Harry, Hobo, Willemijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505305/
https://www.ncbi.nlm.nih.gov/pubmed/33796917
http://dx.doi.org/10.1007/s00262-021-02899-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505305/
https://www.ncbi.nlm.nih.gov/pubmed/33796917
http://dx.doi.org/10.1007/s00262-021-02899-3

Ejemplares similares